You have no items in your shopping cart.
- Item 1 of 1
- Item 1 of 1
Mouse IL-23 [orb2993830]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.7&35.8 KDa. Observed: 40&20 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg- Mouse IL-12B [orb2994366]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 36.8 KDa. Observed: 42-55 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Mouse IL-12RB2 [orb2994394]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 98.4 KDa. Observed: 125-160 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-12RB1 [orb2994431]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 84.2 KDa. Observed: 95-110 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Human IL-12RB1 [orb2994439]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 58.1 KDa. Observed: 80-110 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse IL-23 [orb2994202]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 19.7&35.8 KDa. Observed: 18&40-55 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-23 [orb2994028]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 55.2 KDa. Observed: 60-90 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-12B [orb2994497]
Unconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 34.6 KDa. Observed: 40-47 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg
